US EditionBionova Scientific Expands Capacity and Joins Advanced Therapies Market
Summary by GEN - Genetic Engineering and Biotechnology News…
1 Articles
1 Articles
All
Left
Center
Right
Bionova Scientific Expands Capacity and Joins Advanced Therapies Market
Bionova Scientific, a CDMO, is entering the advanced therapy manufacturing space by installing its third FlexFactory manufacturing platform while maintaining their core monoclonal antibody (mAb) business. Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines. “Using Cytiva’s end-to-end solutions, we’ll have an exceptional platform to support the manufacture of genomic medicines,”…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
